Erythromycin treatment in infants, particularly those in the first two weeks of life, increases the risk of a gastrointestinal disorder called infantile hypertrophic pyloric stenosis (IHPS).
Medicine has recognised the Helicobacter pylori bug as the cause of peptic ulcers - but is becoming increasingly powerless to treat it as its resistance to antibiotics rises.